Revolution Medicines Inc....

0.07
-0.00 (-6.67%)
At close: Mar 28, 2025, 9:30 AM
0.07
0.00%
After-hours: Mar 28, 2025, 04:00 PM EDT

Revolution Medicines Warrant Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue n/a 11.58M 35.38M 29.39M 42.98M 50.04M 20.16M n/a
Cost of Revenue n/a n/a 9.66M 7.33M 132.25M 91.75M 1.76M 1.19M
Gross Profit n/a 11.58M 25.72M 22.06M -89.27M -41.71M 18.4M -1.19M
Operating Income -689.52M -487.19M -258.28M -188.01M -110.7M -54.12M -40.33M -31.13M
Interest Income 86.88M 47.48M 9.15M 929K 2.24M 2.19M 777K 105K
Pretax Income -600.85M -439.89M -249.13M -187.09M -108.53M -52.04M -41.79M -31.13M
Net Income -600.09M -436.37M -248.71M -179.77M -108.16M -47.66M -41.79M -31.13M
Selling & General & Admin 97.3M 75.62M 40.59M 30.45M 21.43M 12.41M 9.41M 4.54M
Research & Development 592.23M 423.14M 253.07M 186.95M 132.25M 91.75M 51.08M 26.59M
Other Expenses n/a n/a n/a n/a n/a n/a -2.12M n/a
Operating Expenses 689.52M 498.76M 293.66M 217.4M 153.68M 104.16M 60.49M 31.13M
Interest Expense n/a 303K n/a 12K 71K 106K 116K 103K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 498.76M 293.66M 217.4M 153.68M 104.16M 60.49M 31.13M
Income Tax 753K -3.52M -420K -7.32M -371K -4.37M -1.34M 105K
Shares Outstanding (Basic) 167.74M 113.15M 80.63M 72.81M 66.6M 59M 36.47M 36.47M
Shares Outstanding (Diluted) 167.74M 113.15M 80.63M 72.81M 66.6M 59M 36.47M 36.47M
EPS (Basic) -3.58 -3.86 -3.08 -2.47 -1.62 -0.81 -1.15 -0.85
EPS (Diluted) -3.58 -3.86 -3.08 -2.47 -1.62 -0.81 -1.15 -0.85
EBITDA -689.52M -430.58M -239.47M -179.75M -101.91M -48.59M -39.91M -29.84M
Depreciation & Amortization n/a 9.31M 9.66M 7.33M 6.54M 3.34M 1.76M 1.19M